DE EN

Select Research Group

Select Year

2012

CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulations and production of pathogenic IdG-antibodies.

Wolf D, Jehle F, Ortiz Rodriguez A, Dufner B, Hoppe N, Colberg C, Lozhkin A, Bassler N, Rupprecht B, Wiedemann A, Hilgendorf I, Stachon P, Willecke F, Febbraio M, von zur Muhlen C, Binder CJ, Bode C, Zirlik A, Peter K.
PLoS One. 2012;7(3):e33026. Epub 2012 Mar 8. Erratum in: PLoS One. 2012;7(5): doi/10.1371/annotation/84102aae-770a-41ae-9c15-4736ed129c17. von zur Muhlen, Constantin [added].
2012

Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.

Winter GE, Rix U, Carlson SM, Gleixner KV, Grebien F, Gridling M, Müller AC, Breitwieser FP, Bilban M, Colinge J, Valent P, Bennett KL, White FM, Superti-Furga G.
Nat Chem Biol. 2012 Nov;8(11):905-12.
2012

The innate immune response to products of phospholipid peroxidation.

Weismann D, Binder CJ.
Biochim Biophys Acta. 2012 Oct;1818(10):2465-75.
2012

Special issue – modular protein domains.

Sudol M, Cesareni G, Superti-Furga G, Just W.
FEBS Lett. 2012 Aug 14;586(17):2571. Epub 2012 Jun 17.
2012

Deconvolution of targeted protein-protein interaction maps.

Stukalov A, Superti-Furga G, Colinge J.
J Proteome Res. 2012 Aug 3;11(8):4102-9. Epub 2012 Jul 10.
2012

Functional drug-gene interactions in lung cancer.

Smida M, Nijman SM.
Expert Rev. Mol. Diagn. 2012 Apr;12(3):291-302.
2012

Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.

Simmer F, Brinkman AB, Assenov Y, Matarese F, Kaan A, Sabatino L, Villanueva A, Huertas D, Esteller M, Lengauer T, Bock C, Colantuoni V, Altucci L, Stunnenberg HG.
Epigenetics. 2012 Dec 1;7(12):1355-67.
2012

Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune response in humans and mice.

Sigel S, Bunk S, Meergans T, Doninger B, Stich K, Stulnig T, Derfler K, Hoffmann J, Deininger S, von Aulock S, Knapp S.
Eur J Immunol. 2012 Jul 18. doi: 10.1002/eji.201242564. [Epub ahead of print].
2012

BAFF (B Cell Activating Factor) Receptor Deficiency Reduces the Development of Atherosclerosis in Mice.

Sage AP, Tsiantoulas D, Baker L, Harrison J, Masters L, Binder CJ, Mallat Z.
Arterioscl Thromb Vasc Biol. 2012 Jul;32(7):1573-6.